世界の高効能医薬品有効成分（API）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14259 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、高効能医薬品有効成分（API）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。高効能医薬品有効成分（API）の種類別市場規模（合成、バイオテクノロジー）、用途別市場規模（腫瘍、ホルモン、緑内障、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・高効能医薬品有効成分（API）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Lonza、Novartis International AG、BASF AG、Carbogen Amcis AG、Eli Lilly and Company、Teva Pharmaceutical Industries Ltd、Bristol-Myers Squibb、Pfizer Inc.、Roche Diagnostics.、Hospira Inc、Boehringer Ingelheim、Medtronic、Merck & Co、Bayer AG、Sigma-Aldrich Corporation、Sanofi Aventis. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：合成、バイオテクノロジー ・用途別分析2016年-2026年：腫瘍、ホルモン、緑内障、その他 ・高効能医薬品有効成分（API）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・高効能医薬品有効成分（API）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・高効能医薬品有効成分（API）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・高効能医薬品有効成分（API）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・高効能医薬品有効成分（API）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The High Potency Active Pharmaceutical Ingredients (APIs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global High Potency Active Pharmaceutical Ingredients (APIs) size is estimated to be xx million in 2021 from USD 15320 million in 2020, with a change of XX% between 2020 and 2021. The global High Potency Active Pharmaceutical Ingredients (APIs) market size is expected to grow at a CAGR of 4.5% for the next five years.

Market segmentation
High Potency Active Pharmaceutical Ingredients (APIs) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Synthetic
Biotech

Market segment by Application can be divided into
Oncology
Hormonal
Glaucoma
Others

The key market players for global High Potency Active Pharmaceutical Ingredients (APIs) market are listed below:
Lonza
Novartis International AG
BASF AG
Carbogen Amcis AG
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd
Bristol-Myers Squibb
Pfizer Inc.
Roche Diagnostics.
Hospira Inc
Boehringer Ingelheim
Medtronic
Merck & Co
Bayer AG
Sigma-Aldrich Corporation
Sanofi Aventis.

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe High Potency Active Pharmaceutical Ingredients (APIs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of High Potency Active Pharmaceutical Ingredients (APIs), with price, sales, revenue and global market share of High Potency Active Pharmaceutical Ingredients (APIs) from 2019 to 2021.
Chapter 3, the High Potency Active Pharmaceutical Ingredients (APIs) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the High Potency Active Pharmaceutical Ingredients (APIs) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and High Potency Active Pharmaceutical Ingredients (APIs) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe High Potency Active Pharmaceutical Ingredients (APIs) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 High Potency Active Pharmaceutical Ingredients (APIs) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Synthetic
1.2.3 Biotech
1.3 Market Analysis by Application
1.3.1 Overview: Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Hormonal
1.3.4 Glaucoma
1.3.5 Others
1.4 Global High Potency Active Pharmaceutical Ingredients (APIs) Market Size & Forecast
1.4.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales in Value (2016-2026))
1.4.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume (2016-2026)
1.4.3 Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Type (2016-2026) & (USD/Unit)
1.5 Global High Potency Active Pharmaceutical Ingredients (APIs) Production Capacity Analysis
1.5.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Total Production Capacity (2016-2026)
1.5.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 High Potency Active Pharmaceutical Ingredients (APIs) Market Drivers
1.6.2 High Potency Active Pharmaceutical Ingredients (APIs) Market Restraints
1.6.3 High Potency Active Pharmaceutical Ingredients (APIs) Trends Analysis
2 Manufacturers Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.1.4 Lonza High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis International AG
2.2.1 Novartis International AG Details
2.2.2 Novartis International AG Major Business
2.2.3 Novartis International AG High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.2.4 Novartis International AG High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 BASF AG
2.3.1 BASF AG Details
2.3.2 BASF AG Major Business
2.3.3 BASF AG High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.3.4 BASF AG High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Carbogen Amcis AG
2.4.1 Carbogen Amcis AG Details
2.4.2 Carbogen Amcis AG Major Business
2.4.3 Carbogen Amcis AG High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.4.4 Carbogen Amcis AG High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.5.4 Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Teva Pharmaceutical Industries Ltd
2.6.1 Teva Pharmaceutical Industries Ltd Details
2.6.2 Teva Pharmaceutical Industries Ltd Major Business
2.6.3 Teva Pharmaceutical Industries Ltd High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business
2.7.3 Bristol-Myers Squibb High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.7.4 Bristol-Myers Squibb High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Pfizer Inc.
2.8.1 Pfizer Inc. Details
2.8.2 Pfizer Inc. Major Business
2.8.3 Pfizer Inc. High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.8.4 Pfizer Inc. High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Roche Diagnostics.
2.9.1 Roche Diagnostics. Details
2.9.2 Roche Diagnostics. Major Business
2.9.3 Roche Diagnostics. High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.9.4 Roche Diagnostics. High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Hospira Inc
2.10.1 Hospira Inc Details
2.10.2 Hospira Inc Major Business
2.10.3 Hospira Inc High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.10.4 Hospira Inc High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.11.4 Boehringer Ingelheim High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Medtronic
2.12.1 Medtronic Details
2.12.2 Medtronic Major Business
2.12.3 Medtronic High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.12.4 Medtronic High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Merck & Co
2.13.1 Merck & Co Details
2.13.2 Merck & Co Major Business
2.13.3 Merck & Co High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.13.4 Merck & Co High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Bayer AG
2.14.1 Bayer AG Details
2.14.2 Bayer AG Major Business
2.14.3 Bayer AG High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.14.4 Bayer AG High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Sigma-Aldrich Corporation
2.15.1 Sigma-Aldrich Corporation Details
2.15.2 Sigma-Aldrich Corporation Major Business
2.15.3 Sigma-Aldrich Corporation High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.15.4 Sigma-Aldrich Corporation High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Sanofi Aventis.
2.16.1 Sanofi Aventis. Details
2.16.2 Sanofi Aventis. Major Business
2.16.3 Sanofi Aventis. High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
2.16.4 Sanofi Aventis. High Potency Active Pharmaceutical Ingredients (APIs) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 High Potency Active Pharmaceutical Ingredients (APIs) Sales by Manufacturer
3.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in High Potency Active Pharmaceutical Ingredients (APIs)
3.4 Market Concentration Rate
3.4.1 Top 3 High Potency Active Pharmaceutical Ingredients (APIs) Manufacturer Market Share
3.4.2 Top 6 High Potency Active Pharmaceutical Ingredients (APIs) Manufacturer Market Share
3.5 Global High Potency Active Pharmaceutical Ingredients (APIs) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and High Potency Active Pharmaceutical Ingredients (APIs) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Market Size by Region
4.1.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume by Region (2016-2026)
4.1.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Region (2016-2026)
4.2 North America High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026)
4.3 Europe High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026)
4.4 Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026)
4.5 South America High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026)
4.6 Middle East and Africa High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume by Type (2016-2026)
5.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Type (2016-2026)
5.3 Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume by Application (2016-2026)
6.2 Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Application (2016-2026)
6.3 Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2026)
7.2 North America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2026)
7.3 North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size by Country
7.3.1 North America High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume by Country (2016-2026)
7.3.2 North America High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2026)
8.2 Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2026)
8.3 Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size by Country
8.3.1 Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume by Country (2016-2026)
8.3.2 Europe High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2026)
9.2 Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2026)
9.3 Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size by Region
9.3.1 Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2026)
10.2 South America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2026)
10.3 South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size by Country
10.3.1 South America High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume by Country (2016-2026)
10.3.2 South America High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2026)
11.2 Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2026)
11.3 Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size by Country
11.3.1 Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 High Potency Active Pharmaceutical Ingredients (APIs) Typical Distributors
12.3 High Potency Active Pharmaceutical Ingredients (APIs) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Type, (USD Million), 2021-2026
Table 2. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Application, (USD Million), 2021-2026
Table 3. Lonza Basic Information, Manufacturing Base and Competitors
Table 4. Lonza Major Business
Table 5. Lonza High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 6. Lonza High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis International AG Major Business
Table 9. Novartis International AG High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 10. Novartis International AG High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. BASF AG Basic Information, Manufacturing Base and Competitors
Table 12. BASF AG Major Business
Table 13. BASF AG High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 14. BASF AG High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Carbogen Amcis AG Basic Information, Manufacturing Base and Competitors
Table 16. Carbogen Amcis AG Major Business
Table 17. Carbogen Amcis AG High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 18. Carbogen Amcis AG High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly and Company Major Business
Table 21. Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 22. Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Ltd Major Business
Table 25. Teva Pharmaceutical Industries Ltd High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 26. Teva Pharmaceutical Industries Ltd High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 28. Bristol-Myers Squibb Major Business
Table 29. Bristol-Myers Squibb High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 30. Bristol-Myers Squibb High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Inc. Major Business
Table 33. Pfizer Inc. High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 34. Pfizer Inc. High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Roche Diagnostics. Basic Information, Manufacturing Base and Competitors
Table 36. Roche Diagnostics. Major Business
Table 37. Roche Diagnostics. High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 38. Roche Diagnostics. High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Hospira Inc Basic Information, Manufacturing Base and Competitors
Table 40. Hospira Inc Major Business
Table 41. Hospira Inc High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 42. Hospira Inc High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Major Business
Table 45. Boehringer Ingelheim High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 46. Boehringer Ingelheim High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Medtronic Basic Information, Manufacturing Base and Competitors
Table 48. Medtronic Major Business
Table 49. Medtronic High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 50. Medtronic High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 52. Merck & Co Major Business
Table 53. Merck & Co High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 54. Merck & Co High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 56. Bayer AG Major Business
Table 57. Bayer AG High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 58. Bayer AG High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Sigma-Aldrich Corporation Basic Information, Manufacturing Base and Competitors
Table 60. Sigma-Aldrich Corporation Major Business
Table 61. Sigma-Aldrich Corporation High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 62. Sigma-Aldrich Corporation High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Sanofi Aventis. Basic Information, Manufacturing Base and Competitors
Table 64. Sanofi Aventis. Major Business
Table 65. Sanofi Aventis. High Potency Active Pharmaceutical Ingredients (APIs) Product and Services
Table 66. Sanofi Aventis. High Potency Active Pharmaceutical Ingredients (APIs) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales by Manufacturer (2019-2021e) & (K Units)
Table 68. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in High Potency Active Pharmaceutical Ingredients (APIs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global High Potency Active Pharmaceutical Ingredients (APIs) Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and High Potency Active Pharmaceutical Ingredients (APIs) Production Site of Key Manufacturer
Table 72. High Potency Active Pharmaceutical Ingredients (APIs) New Entrant and Capacity Expansion Plans
Table 73. High Potency Active Pharmaceutical Ingredients (APIs) Mergers & Acquisitions in the Past Five Years
Table 74. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales by Region (2016-2021e) & (K Units)
Table 75. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales by Region (2021-2026) & (K Units)
Table 76. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Region (2016-2021e) & (USD Million)
Table 77. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Region (2021-2026) & (USD Million)
Table 78. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2021e) & (K Units)
Table 79. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2021-2026) & (K Units)
Table 80. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Type (2016-2021e) & (USD Million)
Table 81. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Type (2021-2026) & (USD Million)
Table 82. Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Type (2016-2021e) & (USD/Unit)
Table 83. Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Type (2021-2026) & (USD/Unit)
Table 84. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2021e) & (K Units)
Table 85. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2021-2026) & (K Units)
Table 86. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Application (2016-2021e) & (USD Million)
Table 87. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Application (2021-2026) & (USD Million)
Table 88. Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Application (2016-2021e) & (USD/Unit)
Table 89. Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Application (2021-2026) & (USD/Unit)
Table 90. North America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Country (2016-2021e) & (K Units)
Table 91. North America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Country (2021-2026) & (K Units)
Table 92. North America High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2016-2021e) & (USD Million)
Table 93. North America High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2021-2026) & (USD Million)
Table 94. North America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2021e) & (K Units)
Table 95. North America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2021-2026) & (K Units)
Table 96. North America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2021e) & (K Units)
Table 97. North America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2021-2026) & (K Units)
Table 98. Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales by Country (2016-2021e) & (K Units)
Table 99. Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales by Country (2021-2026) & (K Units)
Table 100. Europe High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2016-2021e) & (USD Million)
Table 101. Europe High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2021-2026) & (USD Million)
Table 102. Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2021e) & (K Units)
Table 103. Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2021-2026) & (K Units)
Table 104. Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2021e) & (K Units)
Table 105. Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2021-2026) & (K Units)
Table 106. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales by Region (2016-2021e) & (K Units)
Table 107. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales by Region (2021-2026) & (K Units)
Table 108. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Region (2016-2021e) & (USD Million)
Table 109. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2021e) & (K Units)
Table 111. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2021-2026) & (K Units)
Table 112. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2021e) & (K Units)
Table 113. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2021-2026) & (K Units)
Table 114. South America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Country (2016-2021e) & (K Units)
Table 115. South America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Country (2021-2026) & (K Units)
Table 116. South America High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2016-2021e) & (USD Million)
Table 117. South America High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2021-2026) & (USD Million)
Table 118. South America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2021e) & (K Units)
Table 119. South America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2021-2026) & (K Units)
Table 120. South America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2021e) & (K Units)
Table 121. South America High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2021-2026) & (K Units)
Table 122. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales by Country (2016-2021e) & (K Units)
Table 123. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales by Country (2021-2026) & (K Units)
Table 124. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2016-2021e) & (USD Million)
Table 125. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Revenue by Country (2021-2026) & (USD Million)
Table 126. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2016-2021e) & (K Units)
Table 127. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales by Type (2021-2026) & (K Units)
Table 128. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2016-2021e) & (K Units)
Table 129. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales by Application (2021-2026) & (K Units)
Table 130. Direct Channel Pros & Cons
Table 131. Indirect Channel Pros & Cons
Table 132. High Potency Active Pharmaceutical Ingredients (APIs) Typical Distributors
Table 133. High Potency Active Pharmaceutical Ingredients (APIs) Typical Customers
List of Figures
Figure 1. High Potency Active Pharmaceutical Ingredients (APIs) Picture
Figure 2. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Type in 2020
Figure 3. Synthetic
Figure 4. Biotech
Figure 5. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Application in 2020
Figure 6. Oncology
Figure 7. Hormonal
Figure 8. Glaucoma
Figure 9. Others
Figure 10. Global High Potency Active Pharmaceutical Ingredients (APIs) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales (2016-2026) & (K Units)
Figure 13. Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Type (2016-2026) & (USD/Unit)
Figure 14. Global High Potency Active Pharmaceutical Ingredients (APIs) Production Capacity (2016-2026) & (K Units)
Figure 15. Global High Potency Active Pharmaceutical Ingredients (APIs) Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. High Potency Active Pharmaceutical Ingredients (APIs) Market Drivers
Figure 17. High Potency Active Pharmaceutical Ingredients (APIs) Market Restraints
Figure 18. High Potency Active Pharmaceutical Ingredients (APIs) Market Trends
Figure 19. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Manufacturer in 2020
Figure 20. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue Market Share by Manufacturer in 2020
Figure 21. High Potency Active Pharmaceutical Ingredients (APIs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 High Potency Active Pharmaceutical Ingredients (APIs) Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 High Potency Active Pharmaceutical Ingredients (APIs) Manufacturer (Revenue) Market Share in 2020
Figure 24. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Region (2016-2026)
Figure 25. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue Market Share by Region (2016-2026)
Figure 26. North America High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026) & (USD Million)
Figure 27. Europe High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026) & (USD Million)
Figure 29. South America High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Revenue (2016-2026) & (USD Million)
Figure 31. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Type (2016-2026)
Figure 32. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue Market Share by Type (2016-2026)
Figure 33. Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Type (2016-2026) & (USD/Unit)
Figure 34. Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Application (2016-2026)
Figure 35. Global High Potency Active Pharmaceutical Ingredients (APIs) Revenue Market Share by Application (2016-2026)
Figure 36. Global High Potency Active Pharmaceutical Ingredients (APIs) Price by Application (2016-2026) & (USD/Unit)
Figure 37. North America High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Type (2016-2026)
Figure 38. North America High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Application (2016-2026)
Figure 39. North America High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Country (2016-2026)
Figure 40. North America High Potency Active Pharmaceutical Ingredients (APIs) Revenue Market Share by Country (2016-2026)
Figure 41. United States High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Type (2016-2026)
Figure 45. Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Application (2016-2026)
Figure 46. Europe High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Country (2016-2026)
Figure 47. Europe High Potency Active Pharmaceutical Ingredients (APIs) Revenue Market Share by Country (2016-2026)
Figure 48. Germany High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Revenue Market Share by Region (2016-2026)
Figure 57. China High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Type (2016-2026)
Figure 64. South America High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Application (2016-2026)
Figure 65. South America High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Country (2016-2026)
Figure 66. South America High Potency Active Pharmaceutical Ingredients (APIs) Revenue Market Share by Country (2016-2026)
Figure 67. Brazil High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Revenue Market Share by Country (2016-2026)
Figure 73. Turkey High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa High Potency Active Pharmaceutical Ingredients (APIs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source

---